Jin Peng
Zhejiang Provincial Key Laboratory Of Pancreatic Disease
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
OTUD5 maintains STAT1/2 stability and promotes IFNγ-driven intestinal inflammation.
Journal: The Journal of biological chemistry
Published: May 30, 2026
USP25 maintains KRAS expression and inhibiting the deubiquitinase suppresses KRAS signaling in human cancer.
Journal: The Journal of biological chemistry
Published: December 04, 2024
The deubiquitinase USP28 maintains the expression of PPARγ and its inactivation protects mice from diet-induced MASH and hepatocarcinoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 05, 2024
Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: November 04, 2023
The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells.
Journal: The Journal of biological chemistry
Published: December 27, 2022
USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice.
Journal: Nature communications
Published: December 16, 2022
Development and internal validation of a nomogram for predicting survival of nonoperative EGFR-positive locally advanced elderly esophageal cancers.
Journal: Frontiers in oncology
Published: November 14, 2022
Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity.
Journal: Signal transduction and targeted therapy
Published: May 10, 2022
Compare of Interfractional Setup Reproducibility Between Vacuum-Lock Bag and Thermoplastic Mask in Radiotherapy for Breast Cancer.
Journal: Technology in cancer research & treatment
Published: September 23, 2021
Last Updated: 09/26/2026